Show an ad over header. AMP

Trying to prevent cancer cells from metastasizing

Growth of normal tumor cell clusters in a mouse lung (l ) compared to growth of tumor cell clusters when they are prevented from expressing epigen (r). Photo: Kevin Cheung/FredHutch

A signal between breast cancer cells could be a target for new drugs to block the cells from clustering, migrating and metastasizing, researchers said in early findings published in Cell last week.

Why it matters: Metastatic tumors kill nearly 43,000 people from breast cancer, 33,000 from prostate cancer and 135,720 from lung cancer in the U.S. every year. Scientists are seeking ways to prevent a person's cancer from spreading to other organs and becoming more deadly.

Background: Metastatic cancer was thought to mainly originate from single cancer cells traveling to other parts of the body. But there's growing evidence that, at least in some cancers, tumors are more likely to spread throughout the body if they cluster together before traveling through a process called collective cell migration, or collective metastasis.

  • "In this particular study, we show there's a 500-fold increase in metastasis formation for cluster tumor cells [CTCs] compared with the equivalent number of individual tumor cells," study co-author and medical oncologist Kevin Cheung tells Axios.
  • Patients with CTCs tend to have "markedly worse clinical outcomes," says Cheung, assistant professor of the public health sciences division at the Fred Hutchinson Cancer Research Center.
  • CTCs can range from three to dozens of cells that separate from the primary tumor and travel through the bloodstream or lymphatic system.

What they found: Using high resolution imaging to examine clusters of breast cancer cells in mouse and human models, the team discovered a space called "nanolumina" between the cells of each cancer cluster where the cells co-opt a signaling molecule called epigen to promote the growth of clusters.

  • Epigen appears to be accumulating between these nanolumina at about 5,000 times higher concentration than the fluid outside the structure, Cheung says.
  • They found when epigen was suppressed within the nanolumina, primary tumor and metastatic outgrowth was greatly reduced.
  • "Epigen is like a toggle switch. When epigen is high, cluster tumor cells divide and proliferate. ... If we block the epigen within these [nanolumina] compartments, we block metastasis," Cheung says.

What they're saying: Several scientists, who were not part of this study, said finding the nanolumina and epigen is an important early step in better understanding breast cancer metastasis that might later be found to apply to other cancers, too.

  • "These findings are very important and new. Most breast cancer patients are not dying from the primary tumor but from metastasis of their tumors," says Priscilla Hwang, assistant professor of biomedical engineering at Virginia Commonwealth University.
  • "While this study focused on breast cancer, this could potentially be a target to look at for many other cancers as well. Obviously that's not been done yet, but the potential is there," says Aleks Skardal, assistant professor of biomedical engineering at Ohio State University.
  • "Since a lot of metastatic therapies have been designed based on our understanding of single cell metastasis, this may be part of the reason why many therapies have not been effective for treating metastasis," Hwang says.

What they don't know: This may be a general approach for metastasis for different tumor types, but they don't yet know how many tumor types have nanolumina, Cheung says.

  • And any drug therapy targeting epigen would need to be a "balancing act," Skardal points out, as the molecule also plays an important role in normal cell growth.

What's next: After further research, "the next steps are figuring out how to weaponize this against cancer," Skardal says.

Defense makes closing arguments in Chauvin trial

Chauvin's defense attorney Eric Nelson opened his closing argument on Monday by reminding the jury that Derek Chauvin "does not have to prove his innocence."

Why it matters: The jury's verdict in Chauvin's murder trial is seen by advocates as one of the most crucial civil rights cases in decades.

Keep reading... Show less

Merrick Garland: Domestic terrorism is "still with us" and remains critical threat

In his first major speech, Attorney General Merrick Garland warned the nation Monday to remain vigilant against the rising threat of domestic extremism.

Why it matters: Domestic terrorism poses an "elevated threat" to the nation this year, according to U.S. intelligence. Garland has already pledged to crack down on violence linked to white supremacists and right-wing militia groups.

Keep reading... Show less

"Nine minutes and 29 seconds": Prosecutors begin closing arguments in Chauvin trial

Steve Schleicher, an attorney for the prosecution in Derek Chauvin's trial, began closing arguments on Monday by describing in detail George Floyd's last moments — crying out for help and surrounded by strangers, as Chauvin pressed his knee into Floyd for nine minutes and 29 seconds.

Why it matters: The jury's verdict in Chauvin's murder trial, seen by advocates as one of the most crucial civil rights cases in decades, will reverberate across the country and have major implications in the fight for racial justice.

Keep reading... Show less

European soccer goes to war over wealthy clubs' plans for exclusive "Super League"

Europe's biggest soccer clubs have established The Super League, a new midweek tournament that would compete with — and threaten the very existence of — the Champions League.

Why it matters: This new league, set to start in 2023, "would bring about the most significant restructuring of elite European soccer since the 1950s, and could herald the largest transfer of wealth to a small set of teams in modern sports history," writes NYT's Tariq Panja.

Keep reading... Show less

81% of S&P 500 companies have reported a positive earnings surprise for Q1

First-quarter earnings so far have been very strong, outpacing even the rosy expectations from Wall Street and that's a trend that's expected to continue for all of 2021. S&P 500 companies are on pace for one of the best quarters of positive earnings surprises on record, according to FactSet.

Why it matters: The results show that not only has the earnings recession ended for U.S. companies, but firms are performing better than expected and the economy may be justifying all the hype.

Keep reading... Show less

NASA's Mars helicopter takes flight as first aircraft piloted on another planet

NASA successfully piloted the Ingenuity Mars helicopter for its first experimental flight on Monday, briefly hopping the aircraft as NASA's Perseverance rover collected data.

Why it matters: Ingenuity's short flight marks the first time a human-built aircraft has flown on a world other than Earth, opening the door to new means of exploring planets far from our own.

Keep reading... Show less

All U.S. adults now eligible for COVID-19 vaccine, meeting Biden's April 19 deadline

All 50 U.S. states, plus Washington, D.C. and Puerto Rico, have now made U.S. adults over the age of 16 eligible for COVID-19 vaccines, meeting President Biden's April 19 deadline.

Why it matters: The landmark speaks to the increased pace of the national vaccination campaign, but will increase pressure on the federal government, states and pharmaceutical companies to provide adequate vaccine supply and logistics.

Keep reading... Show less

Minneapolis braces for a verdict in the Derek Chauvin trial

Minneapolis is waking up to images of an occupied city on Monday, as the city and the world await a verdict in the Derek Chauvin trial.

What it's like: Residents running errands, picking up dinner and heading to the dog park in recent days encountered heavily-armed National Guard troops stationed throughout the city.

Keep reading... Show less



Get Goodhumans in your inbox

Most Read

More Stories